Asset Search
Displaying all 5 assets.
-
Description Kaplan-Meier Survival Curves for Progression-Free Survival and Multivariate Cox Proportional Hazard Regression Models Corrected for the Number of Pembrolizumab CyclesA, Patients treated with 10...
Article Title: Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression
Publication Title: JAMA Dermatology -
Description Cutaneous Adverse Events in Patients Treated With Pembrolizumab
Article Title: Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression
Publication Title: JAMA Dermatology -
Description Cutaneous Adverse Events During Treatment With PembrolizumabA, Macular papular eruption involving the dorsal surfaces of both hands. B, Macular papular eruption involving the palmar surface of both...
Article Title: Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression
Publication Title: JAMA Dermatology -
Description Grade 3 Cutaneous Adverse Events in a Patient Treated With PembrolizumabA, Macular papular eruption with predilection sites on photoexposed areas of the chest. B, Macular papular eruption with...
Article Title: Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression
Publication Title: JAMA Dermatology -
Description Characteristics of 83 Patients Treated With Pembrolizumab
Article Title: Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression
Publication Title: JAMA Dermatology
Displaying all 5 assets.